These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27878252)

  • 1. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
    Wang Y; Gao S; Wang W; Liang J
    Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.
    Wang N; Zhang Q; Ning B; Luo L; Fang Y
    Biomed Pharmacother; 2017 Jun; 90():368-374. PubMed ID: 28380412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.
    Han S; Li Z; Master LM; Master ZW; Wu A
    Br J Cancer; 2014 Sep; 111(7):1400-9. PubMed ID: 25093489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of ILK promotes temozolomide resistance in glioma cells.
    Liang F; Wang B; Bao L; Zhao YS; Zhang SM; Zhang SQ
    Mol Med Rep; 2017 Mar; 15(3):1297-1304. PubMed ID: 28138714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion Impairment.
    Chen Y; Gao F; Jiang R; Liu H; Hou J; Yi Y; Kang L; Liu X; Li Y; Yang M
    J Cell Biochem; 2017 Dec; 118(12):4905-4913. PubMed ID: 28569417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels.
    Lu XY; Cao K; Li QY; Yuan ZC; Lu PS
    J Int Med Res; 2012; 40(3):995-1004. PubMed ID: 22906272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma.
    Liu XY; Zhang L; Wu J; Zhou L; Ren YJ; Yang WQ; Ming ZJ; Chen B; Wang J; Zhang Y; Yang JM
    PLoS One; 2013; 8(11):e81345. PubMed ID: 24303044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.
    Kim JT; Kim JS; Ko KW; Kong DS; Kang CM; Kim MH; Son MJ; Song HS; Shin HJ; Lee DS; Eoh W; Nam DH
    Oncol Rep; 2006 Jul; 16(1):33-9. PubMed ID: 16786120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
    Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC
    PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of invadopodia formation in temozolomide-resistant or adopted glioma is regulated by c-Jun terminal kinase-paxillin axis.
    Ueno H; Tomiyama A; Yamaguchi H; Uekita T; Shirakihara T; Nakashima K; Otani N; Wada K; Sakai R; Arai H; Mori K
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):240-7. PubMed ID: 26518652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
    Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
    J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
    Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM
    Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells.
    Ma J; Yang YR; Chen W; Chen MH; Wang H; Wang XD; Sun LL; Wang FZ; Wang DC
    Oncol Rep; 2016 Aug; 36(2):676-84. PubMed ID: 27278525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells.
    Zhuang D; Liu Y; Mao Y; Gao L; Zhang H; Luan S; Huang F; Li Q
    Int J Cancer; 2012 Jan; 130(2):309-18. PubMed ID: 21328340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
    Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
    Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
    Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
    Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin.
    Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
    Cancer Biol Ther; 2014 Apr; 15(4):398-408. PubMed ID: 24424202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
    D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
    Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
    Kim SM; Woo JS; Jeong CH; Ryu CH; Jang JD; Jeun SS
    Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.